The May 2024 replay features four episodes on neuro-oncology for brain cancer awareness month. The episode begins with Dr. Philipp Karschnia discussing the assessment of whether MTHFR polymorphisms affect the risk for leukoencephalopathy. The episode continues with Dr. Ingo Mellinghoff discussing new treatment opinions for isocitrate dehydrogenase (IDH)–mutant grade 2 gliomas. The third interview leads into a conversation with Dr. Linda Liau on the study of vaccine-based therapy for GBM. The episode concludes with Dr. Teddy Totimeh talking about brain tumor programs in Asia and Africa.

Podcast Links:

MTHFR Polymorphisms and Leukoencephalopathy Risk in CNS Lymphoma Patients  

New Treatment for IDH mt Gliomas 

Study of Vaccine-Based Therapy for GBM

Brain Tumor Programs in Asia and Africa 

Article Links:

https://doi.org/10.1212/WNL.0000000000207670 

https://www.nejm.org/doi/full/10.1056/NEJMoa2304194

https://jamanetwork.com/journals/jamaoncology/fullarticle/2798847

https://doi.org/10.1016/j.wneu.2023.04.067

Disclosures can be found at Neurology.org.